These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18537651)

  • 1. Treatment of central nervous system involvement associated with primary Sjögren's syndrome.
    Ozgocmen S; Gur A
    Curr Pharm Des; 2008; 14(13):1270-3. PubMed ID: 18537651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelopathy in Sjögren's syndrome: role of nonsteroidal immunosuppressants.
    Rogers SJ; Williams CS; Román GC
    Drugs; 2004; 64(2):123-32. PubMed ID: 14717615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central nervous system involvement in primary Sjögren syndrome].
    Ramírez M; Ramos-Casals M; Graus F
    Med Clin (Barc); 2009 Sep; 133(9):349-59. PubMed ID: 19376547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.
    Delalande S; de Seze J; Fauchais AL; Hachulla E; Stojkovic T; Ferriby D; Dubucquoi S; Pruvo JP; Vermersch P; Hatron PY
    Medicine (Baltimore); 2004 Sep; 83(5):280-291. PubMed ID: 15342972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system (CNS) manifestations of primary Sjögren's syndrome: an overview.
    Alexander EL
    Scand J Rheumatol Suppl; 1986; 61():161-5. PubMed ID: 3473627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide.
    Williams CS; Butler E; Román GC
    Arch Neurol; 2001 May; 58(5):815-9. PubMed ID: 11346378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Sjögren's syndrome with subacute transverse myelitis as the initial manifestation].
    Arai C; Furutani R; Ushiyama M
    Rinsho Shinkeigaku; 2002 Jul; 42(7):613-8. PubMed ID: 12661106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry.
    Mekinian A; Ravaud P; Larroche C; Hachulla E; Gombert B; Blanchard-Delaunay C; Cantagrel A; Fain O; Sibilia J; Gottenberg JE; Mariette X;
    Clin Exp Rheumatol; 2012; 30(2):208-12. PubMed ID: 22341206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Sjogren's syndrome with central nervous system involvement.
    Alhomoud IA; Bohlega SA; Alkawi MZ; Alsemari AM; Omer SM; Alsenani FM
    Saudi Med J; 2009 Aug; 30(8):1067-72. PubMed ID: 19668890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral optic neuropathy revealing Sjögren's syndrome.
    Béjot Y; Osseby GV; Ben Salem D; Beynat J; Muller G; Moreau T; Giroud M
    Rev Neurol (Paris); 2008 Dec; 164(12):1044-7. PubMed ID: 18808771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclophosphamide-responsive subclinical Sjögren's syndrome in a patient with initial peripheral and central nervous system involvement].
    Yamanishi Y; Taooka Y; Mukuzono H; Aoi K; Ishibe Y; Yamana S
    Ryumachi; 1994 Jun; 34(3):633-8. PubMed ID: 8052929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral neurological complications of primary Sjögren's syndrome.
    Fauchais AL; Magy L; Vidal E
    Presse Med; 2012 Sep; 41(9 Pt 2):e485-93. PubMed ID: 22840992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral and central nervous system involvement in a patient with primary Sjögren's syndrome: a case report.
    Ging K; Mono ML; Sturzenegger M; Zbinden M; Adler S; Genitsch V; Wagner F
    J Med Case Rep; 2019 May; 13(1):165. PubMed ID: 31126347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuro-psychiatric involvement in primary Sjögren's syndrome].
    Sagawa A; Tanimura K; Shinohara M; Warabi T
    Nihon Rinsho; 1995 Oct; 53(10):2563-7. PubMed ID: 8531374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of primary Sjögren's syndrome presenting primarily with central nervous system vasculitic involvement.
    Hasiloglu ZI; Albayram S; Tasmali K; Erer B; Selcuk H; Islak C
    Rheumatol Int; 2012 Mar; 32(3):805-7. PubMed ID: 21327424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.
    Govoni M; Padovan M; Rizzo N; Trotta F
    CNS Drugs; 2001; 15(8):597-607. PubMed ID: 11524032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system disease in Sjögren's syndrome.
    Escudero D; Latorre P; Codina M; Coll-Cantí J; Coll J
    Ann Med Interne (Paris); 1995; 146(4):239-42. PubMed ID: 7653943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
    Signoriello E; Sagliocchi A; Fratta M; Lus G
    Acta Neurol Scand; 2015 Feb; 131(2):140-3. PubMed ID: 25622658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
    de Seze J; Delalande S; Fauchais AL; Hachulla E; Stojkovic T; Ferriby D; Hatron PY; Vermersch P
    J Rheumatol; 2006 Apr; 33(4):709-11. PubMed ID: 16583474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.